The COVID-19 Textbook

260

SECTION 3 • Immunology

12. Tellier J, Nutt SL. Plasma cells: the programming of an antibody-secreting machine. Eur J Immunol . 2019;49:30-37. 13. Tonegawa S. Somatic generation of antibody diversity. Nature . 1983;302:575-581. 14. Morea V, Lesk AM, Tramontano A. Antibody modeling: implications for engineering and design. Methods . 2000;20:267-279. 15. Inbar D, Hochman J, Givol D. Localization of antibody-combining sites within the variable portions of heavy and light chains. Proc Natl Acad Sci U S A . 1972;69:2659-2662. 16. Pone EJ, Zan H, Zhang J, Al-Qahtani A, Xu Z, Casali P . Toll-Like receptors and B-Cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses. Crit Rev Immunol . 2010;30:1-29. 17. Rawlings DJ, Schwartz MA, Jackson SW, Meyer-Bahlburg A. Integration of B cell responses through toll-like receptors and antigen receptors. Nat Rev Immunol . 2012;12:282-294. 18. Ruprecht CR, Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol . 2006;36:810-816. 19. Humphrey JH, Frank MM. The localization of non-microbial antigens in the draining lymph nodes of tolerant, normal and primed rabbits. Im munology . 1967;13:87-100. 20. de Silva NS, Klein U. Dynamics of B cells in germinal centres. Nat Rev Immunol . 2015;15:137-148. 21. Schur PH. IgG subclasses. A historical perspective. Monogr Allergy . 1988;23:1-11. 22. van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG . IgA and the IgA Fc receptor. Trends Immunol . 2001;22:205-211. 23. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of the Cell . Garland Science; 2002. 24. Gillis C, Gouel-Cheron A, Jonsson F, Bruhns P. Contribution of human Fc γ Rs to disease with evidence from human polymorphisms and transgenic animal studies. Front Immunol . 2014;5:254. 25. Nimmerjahn F, Ravetch JV. Fc γ receptors as regulators of immune responses. Nat Rev Immunol . 2008;8:34-47. 26. Shibuya A, Sakamoto N, Shimizu Y, et al. Fc α /μ receptor mediates endocytosis of IgM-coated microbes. Nat Immunol . 2000;1:441-446. 27. Meryk A, Pangrazzi L, Hagen M, et al . Fcμ receptor as a costimulatory molecule for T cells. Cell Rep . 2019;26:2681-2691.e5. 28. Motegi Y, Kita H. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils. J Immunol . 1998;161:4340-4346. 29. Mancardi DA, Albanesi M, Jönsson F, et al . The high-affinity human IgG receptor Fc γ RI (CD64) promotes IgG-mediated inflammation, anaphy laxis, and antitumor immunotherapy. Blood . 2013;121:1563-1573. 30. Bruhns P, Jönsson F. Mouse and human FcR effector functions. Immunol Rev . 2015;268:25-51. 31. Junghans RP, Anderson CL. The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport recep tor. Proc Natl Acad Sci U S A . 1996;93:5512-5516. 32. Chaudhury C, Mehnaz S, Robinson JM, et al . The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and pro longs its lifespan. J Exp Med . 2003;197:315-322. 33. Tesar DB, Björkman PJ. An intracellular traffic jam: Fc receptor-mediated transport of immunoglobulin G. Curr Opin Struct Biol . 2010;20:226-233. 34. Antohe F, Rădulescu L, Gafencu A, Gheţie V, Simionescu M. Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Hum Immunol . 2001;62:93-105. 35. Schlachetzki F, Zhu C, Pardridge WM. Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier. J Neurochem . 2002;81:203-206. 36. Baker K, Rath T, Pyzik M, Blumberg RS. The role of FcRn in antigen presentation. Front Immunol . 2014;5:408. 37. Gaebler C, Wang Z, Lorenzi JCC, et al . Evolution of antibody immunity to SARS-CoV-2. Nature . 2021;591:639-644. 38. Sivori S, Vacca P, Del Zotto G, Munari E, Mingari MC, Moretta L . Human NK cells: surface receptors, inhibitory checkpoints, and translational applications. Cell Mol Immunol . 2019;16:430-441. 39. Wohlbold TJ, Podolsky KA, Chromikova V, et al . Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes. Nat Microbiol . 2017;2:1415-1424. 40. Ermler ME, Kirkpatrick E, Sun W, et al . Chimeric hemagglutinin constructs induce broad protection against influenza B virus challenge in the mouse model. J Virol . 2017;91:e00286-17. 41. Bonsignori M, Pollara J, Moody MA, et al . Antibody-Dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family. J Virol . 2012;86:11521-11532. 42. Haynes BF, Gilbert PB, McElrath MJ, et al . Immune-Correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med . 2012;366:1275-1286. 43. Corey L, Gilbert PB, Tomaras GD, Haynes BF, Pantaleo G, Fauci AS. Immune correlates of vaccine protection against HIV-1 acquisition. Sci Transl Med . 2015;7:310rv7. 44. Beaudoin-Bussières G, Arduini A, Bourassa C, et al . SARS-CoV-2 accessory protein ORF8 decreases antibody-dependent cellular cytotoxicity. Viruses . 2022;14:1237. 45. Ding S, Adam D, Beaudoin-Bussières G, et al . SARS-CoV-2 spike expression at the surface of infected primary human airway epithelial cells. Viruses . 2021;14:5. 46. Anand SP, Prévost J, Nayrac M, et al . Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset. Cell Rep Med . 2021;2:100290. 47. Freeman SA, Grinstein S. Phagocytosis: receptors, signal integration, and the cytoskeleton. Immunol Rev . 2014;262:193-215. 48. Nirmala JG, Lopus M. Cell death mechanisms in eukaryotes. Cell Biol Toxicol . 2020;36:145-164. 49. Stacey HD, Golubeva D, Posca A, et al . IgA potentiates NETosis in response to viral infection. Proc Natl Acad Sci U S A . 2021;118:e2101497118. 50. Barouch DH, Stephenson KE, Borducchi EN, et al . Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in Rhesus monkeys. Cell . 2013;155:531-539. 51. Barouch DH, Alter G, Broge T, et al . Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys. Science . 2015;349:320-324. 52. Zaiss AK, Vilaysane A, Cotter MJ, et al . Antiviral antibodies target adenovirus to phagolysosomes and amplify the innate immune response. J Immunol . 2009;182:7058-7068. 53. Vogt MR, Dowd KA, Engle M, et al . Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fc γ receptor and complement-dependent effector mechanisms. J Virol . 2011;85:11567-11580. 54. Quattrocchi V, Langellotti C, Pappalardo JS, et al . Role of macrophages in early protective immune responses induced by two vaccines against foot and mouth disease. Antiviral Res . 2011;92:262-270. 55. McCullough KC, Parkinson D, Crowther JR. Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology . 1988;65:187-191. 56. Gaboriaud C, Thielens NM, Gregory LA, Rossi V, Fontecilla-Camps JC, Arlaud GJ . Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol . 2004;25:368-373. 57. Borsos T, Rapp HJ. Complement fixation on cell surfaces by 19 S and 7 S antibodies. Science . 1965;150:505-506. 58. Diebolder CA, Beurskens FJ, de Jong RN, et al . Complement is activated by IgG hexamers assembled at the cell surface. Science . 2014;343:1260-1263. 59. Co MD, Terajima M, Thomas SJ, et al . Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 influenza in children. Viral Immunol . 2014;27:375-382. 60. Wu Y, Cho M, Shore D, et al . A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus. Nat Commun . 2015;6:7708.

Copyright © 2023 Wolters Kluwer, Inc. Unauthorized reproduction of the content is prohibited.